• 제목/요약/키워드: Contrast-enhanced CT

검색결과 174건 처리시간 0.03초

Generation of contrast enhanced computed tomography image using deep learning network

  • Woo, Sang-Keun
    • 한국컴퓨터정보학회논문지
    • /
    • 제24권3호
    • /
    • pp.41-47
    • /
    • 2019
  • In this paper, we propose a application of conditional generative adversarial network (cGAN) for generation of contrast enhanced computed tomography (CT) image. Two types of CT data which were the enhanced and non-enhanced were used and applied by the histogram equalization for adjusting image intensities. In order to validate the generation of contrast enhanced CT data, the structural similarity index measurement (SSIM) was performed. Prepared generated contrast CT data were analyzed the statistical analysis using paired sample t-test. In order to apply the optimized algorithm for the lymph node cancer, they were calculated by short to long axis ratio (S/L) method. In the case of the model trained with CT data and their histogram equalized SSIM were $0.905{\pm}0.048$ and $0.908{\pm}0.047$. The tumor S/L of generated contrast enhanced CT data were validated similar to the ground truth when they were compared to scanned contrast enhanced CT data. It is expected that advantages of Generated contrast enhanced CT data based on deep learning are a cost-effective and less radiation exposure as well as further anatomical information with non-enhanced CT data.

Safety of Administering Intravenous CT Contrast Agents Repeatedly or Using Both CT and MRI Contrast Agents on the Same Day: An Animal Study

  • Heejin Bae;Hyewon Oh;Ga Bin Park;Yong Eun Chung
    • Korean Journal of Radiology
    • /
    • 제25권3호
    • /
    • pp.257-266
    • /
    • 2024
  • Objective: To investigate molecular and functional consequences of additional exposures to iodine- or gadolinium-based contrast agents within 24 hours from the initial intravenous administration of iodine-based contrast agents through an animal study. Materials and Methods: Fifty-six Sprague-Dawley male rats were equally divided into eight groups: negative control, positive control (PC) with single-dose administration of CT contrast agent, and additional administration of either CT or MR contrast agents 2, 4, or 24 hours from initial CT contrast agent injection. A 12 µL/g of iodinated contrast agent or a 0.47 µL/g of gadolinium-based contrast agent were injected into the tail vein. Serum levels of blood urea nitrogen, creatinine, cystatin C (Cys C), and malondialdehyde (MDA) were measured. mRNA and protein levels of kidney injury molecule-1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) were evaluated. Results: Levels of serum creatinine (SCr) were significantly higher in repeated CT contrast agent injection groups than in PC (0.21 ± 0.02 mg/dL for PC; 0.40 ± 0.02, 0.34 ± 0.03, and 0.41 ± 0.10 mg/dL for 2-, 4-, and 24-hour interval groups, respectively; P < 0.001). There was no significant difference in the average Cys C and MDA levels between PC and repeated CT contrast agent injection groups (Cys C, P = 0.256-0.362; MDA, P > 0.99). Additional doses of MR contrast agent did not make significant changes compared to PC in SCr (P > 0.99), Cys C (P = 0.262), and MDA (P = 0.139-0.771) levels. mRNA and protein levels of KIM-1 and NGAL were not significantly different among additional CT or MR contrast agent groups (P > 0.05). Conclusion: A sufficient time interval, probably more than 24 hours, between repeated contrast-enhanced CT examinations may be necessary to avoid deterioration in renal function. However, conducting contrast-enhanced MRI on the same day as contrast-enhanced CT may not induce clinically significant kidney injury.

토끼 뇌감염 모델의 CT 소견과 조영제 주입 후 동맥혈의 Hounsfield Unit의 변화 (CT Scan Findings of Rabbit Brain Infection Model and Changes in Hounsfield Unit of Arterial Blood after Injecting Contrast Medium)

  • 하본철;곽병국;정지성
    • 한국콘텐츠학회논문지
    • /
    • 제12권9호
    • /
    • pp.270-279
    • /
    • 2012
  • 토끼 뇌에 대장균을 주입하여 CT 소견을 알아보고, 시간에 따른 동맥혈의 하운스필드 값의 변화를 알아보고자 하였다. 토끼 두개관에 천두공(burr hole)을 뚫고 2~3 mm 깊이에 대장균 $1{\times}10^7$ CFU/ml, 0.1 ml을 주입하여 뇌염증 모델을 제작하고, 조영 증강 CT와 동적 CT, 그리고 동맥혈의 CT영상을 얻었다.조영 증강 CT에서 뇌농양, 뇌실염 그리고 뇌막염등 다양한 뇌염증 소견이 보였다. 뇌농양은 중앙부가 거의 조영되지 않고 주변부가 강하게 조영되는 전형적인 양상을 보였고, 뇌실염은 측뇌실 벽을 따라 강하게 조영되는 소견을 보였으며, 뇌막염은 종뇌와 간뇌의 접히는 부위 뇌막이 강하게 조영되었다. 동적 CT영상에서 염증 중앙부의 조영제 주입 전 HU 값은 $31.01{\pm}3.55$였고, 주입 후 10분까지 $40.36{\pm}3.76$으로 서서히 증가하였다. 그리고 염증 가장자리구역에서 HU 값은 조영제 주입 전에 $47.23{\pm}3.12$였고, 조영제 주입 후 약 45초에 $63.59{\pm}3.31$로 가장 많이 증가 하였으나 이후 20분까지 약간 떨어졌다. 또한 균 주입 반대쪽 정상 뇌조직에서 측정한 HU 값은 조영제 주입 전에 $39.01{\pm}3.24$이었고, 조영제 주입 후 약 30초에 $49.01{\pm}4.29$로 가장 많이 조영되었고, 이후 서서히 낮아졌다. 동맥 혈액 CT에서 조영제 주입 전 HU 값은 $87.78{\pm}6.88$이었고, 조영제 주입 후 10초부터 30초까지 급격히 증가하여 $749.13{\pm}98.48$로 최대값을 보이고, 30초부터 45초까지 $467.85{\pm}62.98$로 급격히 감소하며, 45초에서 60초까지는 정체기(plateau)를 보였으며, 이후 20분까지 $188.28{\pm}25.03$으로 감소되었다. 결과적으로 대장균으로 뇌염증 모델을 만들 수 있고, 조영 증강 CT를 통하여 뇌염증의 특징적인 소견을 잘 알 수 있었으며, 동적 CT를 통해 염증 중앙부와 가장자리구역의 조영 양상을 알 수 있고, 동맥혈은 조영제 주입 후 10초부터 30초 까지 급격히 증가하다 정체기를 거쳐 서서히 감소하는 것으로 나타났다.

CT 조영제 혈관외유출의 방사선학적 고찰 (Radiological Evaluation of CT Contrast Medium Extravasation)

  • 권대철;박창희;정재호;강희두;송은홍
    • 대한디지털의료영상학회논문지
    • /
    • 제10권2호
    • /
    • pp.39-49
    • /
    • 2008
  • Extravasation of contrast material is a not infrequent complication of enhanced imaging studies and large volume extravasation may result in severe damage. Subcutaneous extravasation of the radiographic contrast medium is one of the complications of the contrast medium-enhanced procedures. Automated power injectors enable the contrast material to be delivered at a uniform high-flow-rate and as a nonfragmented bolus, and this is essential for many contrast material enhanced CT(computed tomography) applications. The major risk associated with the use of automated power injectors is the well known complication of contrast material extravasation at the injection site. Automated injection of CT contrast material can produce the compartment syndrome. Selection of the nonionic contrast material after careful evaluation of the intravenous administration site and monitoring of the patient during the use of a mechanical power injector may help minimize or prevent extravasation injuries. Early identification is important and conservative management is effective in most cases. Prevention of these injuries with the education of radiological technologist remains the ultimate aim.

  • PDF

PET/CT 영상에서 조영제를 사용하지 않은 CT와 조영제를 사용한 CT를 이용한 감쇠보정에 따른 표준화섭취계수의 비교 (A Comparative Study of the Standard Uptake Values of the PET Reconstruction Methods; Using Contrast Enhanced CT and Non Contrast Enhanced CT)

  • 이승재;박훈희;안샤론;오신현;남궁혁;임한상;김재삼;이창호
    • 핵의학기술
    • /
    • 제12권3호
    • /
    • pp.235-240
    • /
    • 2008
  • PET/CT 검사의 사용 초기에 CT는 주로 감쇠보정(Attenuation Correction: AC)의 목적으로 사용되어졌지만, CT의 성능이 향상됨으로써 조영제를 이용한 CT검사를 진단에 반영하여 보다 진보된 진단적 가치를 가질 수 있게 되었다. 조영제의 사용이 없이도 CT를 판독할 수 있지만 병변의 정확한 범위를 확인하고 정상 구조물을 구별하는데 있어서 조영제의 사용은 판독자로 하여금 판독을 매우 용이하게 하는 도움을 줄 수 있다. 하지만, 그동안 PET/CT검사 시 조영제가 감쇠보정에 영향을 줄 수 있다는 논쟁으로 이견이 많았다. 40-140 keV 정도의 낮은 엑스선을 이용하는 CT영상에 비하여, 조영제를 사용한 CT영상에서는 조영제로 인해 감쇠가 많이 되지만 511 keV의 에너지를 가진 감마선은 조영제로 인해 거의 영향을 받지 않게 되고 이로 인해 감쇠보정 시 과보정을 하게 되어 PET영상에서 오류를 나타낼 수 있다는 의견이 보고되기도 하였다. 이와는 반대로 조영제가 감쇠보정에 과대평가를 가져올 수 있다는 의견과 과보정으로 인한 표준화섭취계수에 변화의 가능성은 있으나 결정적인 영향을 미치지 않는다는 의견도 제시되었다. 본 연구에서는 조영제의 영향이 SUV에 어떠한 영향을 미치는지에 대해서만 비교 평가하였다. 2007년 12월에서 2008년 6월 사이에 본원에서 PET/CT 검사를 시행한 환자 중 요오드 조영제에 대한 부작용이 없고 당뇨병이 없는 진행성 암 환자 30명을 대상으로 하였으며, DSTe (General Electric Healthcare, Milwaukee, MI, USA)를 사용하여, 각각의 환자는 조영제를 사용하지 않은 CT를 시행한 후 PET영상을 얻었고 그 후, 조영제를 사용한 CT검사를 하였다. 각각의 CT정보로 감쇠보정을 실시, 종류별로 PET영상을 획득하여, 각 영상에 동일한 관심영역(Region of Interests : ROIs)을 설정 후, SUV를 비교 하였다. 얻어진 두 가지 결과 값의 정량 분석의 비교를 위해서 대응표본 T-검정 (Paired t-test)을 사용하였다. 검사를 시행한 30명의 환자에게서 폐, 간, 심장의 $SUV_{max}$ 값과 $SUV_{mean}$값을 측정하여 총 180개 영역을 분석하였다. 조영제를 사용하기 전과 후를 비교하였을 때, 측정한 거의 모든 영역에서 조영 후의 $SUV_{max}$$SUV_{mean}$가 상승하였고 통계적으로도 유의한 것으로 나타났다(p value<0.05). 심장 영역에서 조영 전 보다 조영 후의 $SUV_{mean}$값이 증가된 것으로 나타났지만, 통계적으로 유의하게 나타나지는 않았다. 조영제를 사용한 CT영상의 SUV값이 과보정되어, 조영제를 사용하지 않은 CT의 SUV 보다 높게 나왔으나 기존의 보고된 논문에서는 이와 같은 결과는 실제 임상 판독에 있어서 큰 영향을 미치지 않는다고 보고되어 있다. 그러나 원발성병변의 진행을 알아보는 과정에서는 SUV의 작은 변동도 분명 영향을 줄 수 있으므로 간 영역과 같이 SUV의 변동이 다른 영역에 비해 상대적으로 큰 영역에서는 수치의 변화에 대한 주의가 요구 될 것으로 사료된다.

  • PDF

Contrast Enhanced Ultrasonography and CT Features of Gastrointestinal Stromal Tumor in a Dog

  • Saran Chhoey;Soyeon Kim;Kroesna Kang;Sath Keo;Jihye Choi
    • 한국임상수의학회지
    • /
    • 제40권5호
    • /
    • pp.375-381
    • /
    • 2023
  • A large abdominal mass was incidentally found in a 13-year-old mixed-breed dog and was confirmed to be a cecal gastrointestinal stromal tumor (GIST). Contrast-enhanced ultrasound and post-contrast computed tomography (CT) showed mild contrast enhancement of the mass, indicating low blood flow. The tumor origin was determined to be the cecum by identifying the vessels supplying the mass on post-contrast CT. The exophytic growth of the tumor left the cecal lumen intact without obstruction. This report described the CEUS and CT perfusion of the cecal GIST and perfusion evaluation can help diagnose and characterize GISTs in dogs.

Hepatic Cavernous Hemangioma in Cirrhotic Liver: Imaging Findings

  • Jeong-Sik Yu;Ki Whang Kim;Mi-Suk Park;Sang-Wook Yoon
    • Korean Journal of Radiology
    • /
    • 제1권4호
    • /
    • pp.185-190
    • /
    • 2000
  • Objective: To document the imaging findings of hepatic cavernous hemangioma detected in cirrhotic liver. Materials and Methods: The imaging findings of 14 hepatic cavernous hemangiomas in ten patients with liver cirrhosis were retrospectively analyzed. A diagnosis of hepatic cavernous hemangioma was based on the findings of two or more of the following imaging studies: MR, including contrast-enhanced dynamic imaging (n = 10), dynamic CT (n = 4), hepatic arteriography (n = 9), and US (n = 10). Results: The mean size of the 14 hepatic hemangiomas was 0.9 (range, 0.5-1.5) cm in the longest dimension. In 11 of these (79%), contrast-enhanced dynamic CT and MR imaging showed rapid contrast enhancement of the entire lesion during the early phase, and hepatic arteriography revealed globular enhancement and rapid filling-in. On contrast-enhanced MR images, three lesions (21%) showed partial enhancement until the 5-min delayed phases. US indicated that while three slowly enhancing lesions were homogeneously hyperechoic, 9 (82%) of 11 showing rapid enhancement were not delineated. Conclusion: The majority of hepatic cavernous hemangiomas detected in cirrhotic liver are small in size, and in many, hepatic arteriography and/or contrast-enhanced dynamic CT and MR imaging demonstrates rapid enhancement. US, however, fails to distinguish a lesion of this kind from its cirrhotic background.

  • PDF

Value of FDG PET/Contrast-Enhanced CT in Initial Staging of Colorectal Cancer - Comparison with Contrast-Enhanced CT

  • Kunawudhi, Anchisa;Sereeborwornthanasak, Karun;Promteangtrong, Chetsadaporn;Siripongpreeda, Bunchorn;Vanprom, Saiphet;Chotipanich, Chanisa
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제17권8호
    • /
    • pp.4071-4075
    • /
    • 2016
  • Background: FDG PET/CT is at an equivocal stage to recommend for staging of colorectal cancer as compared to contrast-enhanced CT (ceCT). This study was intended to evaluate the value of FDG PET/ceCT in colorectal cancer staging as compared to ceCT alone. Materials and Methods: PET/ceCT was performed for 61 colorectal cancer patients who were prospectively enrolled in the study. Three patients were excluded due to loss to follow-up. PET/ceCT findings and ceCT results alone were read separately. The treatment planning was then determined by tumor board consensus. The criteria for T staging were determined by the findings of ceCT. Nodal positive by PET/ceCT imaging was determined by visual analysis of FDG uptake greater than regional background blood pool activity. The diagnostic accuracy of T and N staging was determined only in patients who received surgery without any neoadjuvant treatment. Results: Of 58 patients, there were 40 with colon cancers including sigmoid cancers and 18 with rectal cancers. PET/ceCT in pre-operative staging detected bone metastasis and metastatic inguinal lymph nodes (M1a) that were undepicted on CT in 2 patients (3%), clearly defined 19 equivocal lesions on ceCT in 18 patients (31%) and excluded 6 metastatic lesions diagnosed by ceCT in 6 patients (10%). These resulted in alteration of management plan in 15 out of the 58 cases (26%) i.e. changing from chemotherapy to surgery (4), changing extent of surgery (9) and avoidance of futile surgery (2). Forty four patients underwent surgery within 45 days after PET/CT. The diagnostic accuracy for N staging with PET/ceCT and ceCT alone was 66% and 48% with false positive rates of 24% (6/25) and 76% (19/25) and false negative rates of 47% (9/19) and 21% (4/19), respectively. All of the false negative lymph nodes from PET/ceCT were less than a centimeter in size and located in peri-lesional regions. The diagnostic accuracy for T staging was 82%. The sensitivity of the peri-lesional fat stranding sign in determining T3 stage was 94% and the specificity was 54%. Conclusions: Our study suggested promising roles of PET/ceCT in initial staging of colorectal cancer with better diagnostic accuracy facilitating management planning.

Diagnosis of Hepatocellular Carcinoma Using C-11 Choline PET/CT: Comparison with F-18 FDG, Contrast-Enhanced MRI and MDCT

  • Chotipanich, Chanisa;Kunawudhi, Anchisa;Promteangtrong, Chetsadaporn;Tungsuppawattanakit, Puntira;Sricharunrat, Thaniya;Wongsa, Paramest
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제17권7호
    • /
    • pp.3569-3573
    • /
    • 2016
  • Purpose: The aim of this study was to compare C-11 choline and F-18 FDG PET/CT, gadoxetic-enhanced 3-T MRI and contrast-enhanced CT for diagnosis of hepatocellular carcinoma (HCC). Materials and Methods: Twelve chronic hepatitis B patients suspected of having HCC by abdominal ultrasonography received all diagnostic modalities performed within a one-week timeslot. PET/CT results were analyzed visually by two independent nuclear medicine physicians and quantitatively by tumor to background ratio (T/B). Nine patients then had histopathological confirmation. Results: Six patients had well differentiated HCC, while two and one patient(s) were noted with moderately and poorly differentiated HCC, respectively. All were detected by both CT and MRI with an average tumor size of $5.7{\pm}3.8cm$. Five patients had positive C-11 choline and F-18 FDG uptake. Of the remaining four patients, three with well differentiated HCC showed negative F-FDG uptake (one of which showed negative results by both tracers) and one patient with moderately differentiated HCC demonstrated no C-11 choline uptake despite intense F-18 FDG avidity. The overall HCC detection rates with C-11 choline and F-18 FDG were 78% and 67%, respectively, while the sensitivity of F-18 FDG for non-well differentiated HCC was 100%, compared with 83% of C-11 choline. The average T/B of C-11 choline in well-differentiated HCC patients was higher than in moderately and poorly differentiated cases (p=0.5) and vice versa with statistical significance for T/B of F-18 FDG (p = 0.02). Conclusions: Our results suggested better detection rate in C-11 choline for well differentiated HCC than F-18 FDG PET. However, the overall detection rate of PET/CT with both tracers could not compare with contrast-enhanced CT and MRI.

Pharmacokinetic Compartment Modeling을 이용한 나선식 CT에서의 간암-간 대조 곡선의 Simulation (Simulation of lesion-to-liver contrast difference curves in Dynamic Hepatic CT with Pharmacokinetic Compartment Modeling)

  • S.J. Kim;K.H. Lee;J.H. Kim;J.K. Han;B.G. Min
    • 대한의용생체공학회:의공학회지
    • /
    • 제20권2호
    • /
    • pp.173-182
    • /
    • 1999
  • 조영 증강제를 이용한 나선식 CT는 간 질환을 진단하는데 있어 중요한 역할을 하고있음에도 불구하고 진단의 효율을 최적화하는 프로토콜은 명확하게 알려져 있지 않다. 따라서 나선식 CT에서의 간암-간 대조 곡선을 모의 실험(simulation) 하여 다양한 요소들이 시간-조영 곡선에 어떻게 영향을 미치는지 파악하고, 또한 CT 검사 전에 모의 실험을 하여 이론적으로 최적의 스캔을 할 수 있도록 하기 위하여 약동학(pharmacokinetics)에 기초한 compartment model을 구성하였다. 간암, 간, 대동맥 및 간문맥 등을 각 구획(compartment)으로 설정하여 각 구획에서의 미분방정식을 얻은 후 적분하여 Hounsfield unfit 값을 조영제 주입 후 시간의 함수로 얻었으며 각 구획의 시간-조영 곡선을 출력하였다. 구현한 프로그램에서는 간암의 크기 및 종양 혈관의 분포 등과 같은 간암의 성질, 간경화의 정도에 따른 간 혈관 공급의 양상 및 조영제의 부피, 농도, 주입 속도 등의 조영제 주입 방법, 환자의 몸무게, 키 등의 환자의 신체 계수, 그리고 심박출량 등의 환자의 혈역학적 계수 등을 입력 받아 간암을 비롯한 각 구획의 시간-조영 곡선 및 간-간암 대조 곡선을 출력할 수 있도록 하였다. 모델링을 통해 얻은 조영 증강 곡선은 같은 환경하에서 얻은 24명의 환자 데이터와 비교하여 유사한 결과를 얻을 수 있었으며, 조영 증강제 주입 방법의 변화가 간암-간 대조 곡선에 미치는 영향을 비교할 수 있었다.

  • PDF